Published in Z Urol Nephrol on November 01, 1989
PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur J Pharmacol (1992) 2.43
Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J Med Genet (2003) 1.92
Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein. Clin Pharmacol Ther (2000) 1.61
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther (2005) 1.36
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction. Clin Pharmacol Ther (2000) 1.27
Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex. Pharmacogenomics J (2006) 1.24
Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res (2001) 1.11
The effect of rifampin treatment on intestinal expression of human MRP transporters. Am J Pathol (2000) 1.04
N-acetylation and debrisoquine type oxidation polymorphism in Caucasians--with reference to age and sex. Int J Clin Pharmacol Ther Toxicol (1990) 1.02
Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function. Pharmacogenomics J (2010) 1.01
Genetic influences on baroreflex function in normal twins. Hypertension (2001) 1.01
Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. J Pharmacol Methods (1983) 1.01
Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrinol Metab (2001) 1.00
Osmosensitive mechanisms contribute to the water drinking-induced pressor response in humans. Neurology (2005) 0.98
Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by α1-microglobulin. Placenta (2011) 0.93
The classification of antiseptic products to be administered to wounds--another borderline case between medicinal products and medical devices? Int J Clin Pharmacol Ther (2006) 0.92
Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int J Immunopharmacol (1993) 0.91
LC-MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins. J Pharm Biomed Anal (2013) 0.89
Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. Eur J Pharm Biopharm (2008) 0.88
Intraoperative tramadol reduces shivering but not pain after remifentanil-isoflurane general anaesthesia. A placebo-controlled, double-blind trial. Eur J Anaesthesiol (2008) 0.87
New functionally selective muscarinic agonists. Life Sci (1993) 0.86
Disposition kinetics of metronidazole in children. Eur J Clin Pharmacol (1983) 0.86
Reference tables for the intrasubject coefficient of variation in bioequivalence studies. Int J Clin Pharmacol Ther (1995) 0.85
Investigation of the anti-inflammatory potential of Aloe vera gel (97.5%) in the ultraviolet erythema test. Skin Pharmacol Physiol (2008) 0.84
Improved detection of bacterial central nervous system infections by use of a broad-range PCR assay. J Clin Microbiol (2014) 0.84
Molecular characterisation of linezolid resistance in two vancomycin-resistant (VanB) Enterococcus faecium isolates using Pyrosequencing. Eur J Clin Microbiol Infect Dis (2008) 0.83
Limited effect of systemic beta-blockade on sympathetic outflow. Hypertension (2001) 0.83
Noncollinear magnetic order in quasicrystals. Phys Rev Lett (2004) 0.82
Pharmacokinetic and pharmacodynamic interactions between the immunosuppressant sirolimus and the lipid-lowering drug ezetimibe in healthy volunteers. Clin Pharmacol Ther (2010) 0.82
Impact of efavirenz on intestinal metabolism and transport: insights from an interaction study with ezetimibe in healthy volunteers. Clin Pharmacol Ther (2012) 0.82
Mouse interferon-gamma in liposomes: pharmacokinetics, organ-distribution, and activation of spleen and liver macrophages in vivo. J Interferon Res (1989) 0.82
Roflumilast, a once-daily oral phosphodiesterase 4 inhibitor, lacks relevant pharmacokinetic interactions with inhaled salbutamol when co-administered in healthy subjects. Int J Clin Pharmacol Ther (2006) 0.81
Anticholinergic properties of propiverine and its metabolites. Pharmazie (1990) 0.80
[Phenylalanine hydroxylase activity in hyperphenyl-alaninemia and classical phenylketonuria]. Acta Biol Med Ger (1972) 0.80
Pharmacokinetics of Metronidazole in pregnant women. Chemotherapy (1981) 0.80
Polymorphism of the N-acetyltransferase (NAT2), smoking and the potential risk of periodontal disease. Arch Toxicol (2000) 0.80
Transporter-mediated uptake into cellular compartments. Xenobiotica (2007) 0.80
Compartment-specific gene regulation of the CAR inducer efavirenz in vivo. Clin Pharmacol Ther (2012) 0.79
Drug interactions between the immunosuppressant tacrolimus and the cholesterol absorption inhibitor ezetimibe in healthy volunteers. Clin Pharmacol Ther (2011) 0.79
The immunological evidence for a phenylalanine hydroxylase like immunoreactive protein in different human cells and tissues. Clin Chim Acta (1990) 0.79
Influence of propiverine on hepatic microsomal cytochrome p450 enzymes in male rats. Drug Metab Dispos (2003) 0.78
Relationship between human genotype and phenotype of N-acetyltransferase (NAT2) as estimated by discriminant analysis and multiple linear regression: 1. Genotype and N-acetylation in vivo. Pharmacogenetics (1997) 0.78
[Prenatal diagnosis of X chromosome recessive ichthyosis in uncultured chorion cells]. Dermatol Monatsschr (1988) 0.78
Genetic influences on the pharmacokinetics of orally and intravenously administered digoxin as exhibited by monozygotic twins. Clin Pharmacol Ther (2009) 0.78
[Methods of suicide in an autopsy sample of the Institute of Forensic Medicine of the Hannover Medical School]. Arch Kriminol (1997) 0.77
[Studies on the metabolism of the bladder spasmolytic, propiverin (mictonorm) in humans]. Pharmazie (1988) 0.77
Immunotherapy of murine visceral leishmaniasis with murine recombinant interferon-gamma and MTP-PE encapsulated in liposomes. J Interferon Res (1991) 0.77
Biochemical and immunological characterization of X-linked ichthyosis. J Inherit Metab Dis (1993) 0.77
[Differential value of various vital stains of corneal endothelium]. Ophthalmologe (1995) 0.77
[Phenylalanine hydroxylase activity in heterozygote hereditary carriers of the phenylketonuria gene]. Acta Biol Med Ger (1977) 0.77
Kinetics of propiverine as assessed by radioreceptor assay in poor and extensive metabolizers of debrisoquine. Eur J Drug Metab Pharmacokinet (1994) 0.77
Prediction of metabolic activity from genotype: the gene-dose effect of N-acetyltransferase. Ther Drug Monit (2001) 0.77
N-Acetylation phenotyping with sulfamethazine--problems of sampling. Pharmazie (1989) 0.77
N-acetylator phenotypes in hyperthyroidism. Int J Clin Pharmacol Ther Toxicol (1988) 0.77
[The quantitative identification of metabolites of dihydralazine in the human]. Pharmazie (1988) 0.77
Arylsulphatase C activity in leukocytes of patients and carriers of X-linked ichthyosis. J Inherit Metab Dis (1987) 0.77
Oxidation phenotyping with debrisoquine in Germany (East). Pharmazie (1990) 0.77
Determination of propiverine and its metabolites in rat samples by liquid chromatography-tandem mass spectrometry. J Chromatogr A (2006) 0.77
Tyramine in the assessment of regional adrenergic function. Biochem Pharmacol (2006) 0.77
The effect of oral glucose loads on tissue metabolism during angiotensin II receptor and beta-receptor blockade in obese hypertensive subjects. Horm Metab Res (2006) 0.76
The anticholinergic drug propiverine inhibits the protein kinase C activity in the rat urinary bladder. Pharmazie (2005) 0.76
Kidney transplantation improves quality of life. Transplant Proc (1997) 0.76
[Pharmacokinetic problems in clinical practice: role of drug transporters]. Dtsch Med Wochenschr (2009) 0.76
Effects of interferon-gamma and streptolysin O on hepatic procainamide N-acetyltransferase and various microsomal cytochrome P450-dependent monooxygenases in rats. Immunopharmacol Immunotoxicol (1996) 0.76
Bioavailability studies of calcium dobesilate--a case of flip-flop kinetics. Pharmazie (1985) 0.76
N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndrome. Br J Clin Pharmacol (1991) 0.75
Tiracizine disposition in healthy volunteers with reference to the debrisoquine oxidation phenotype. Br J Clin Pharmacol (1995) 0.75
Hypothalamic neuropeptide release after experimental subarachnoid hemorrhage: in vivo microdialysis study. Acta Neurol Scand (2004) 0.75
Pharmacokinetic interactions between isoniazid and theophylline in rats. J Pharm Pharmacol (1992) 0.75
[Detection of phenylalanine hydroxylase activity in leukocytes and fibroblasts]. Biomed Biochim Acta (1983) 0.75
[Antibody response to hemagglutinin and neuraminidase induced by an influenza subunit vaccine (author's transl)]. Zentralbl Bakteriol Orig A (1979) 0.75
Trichloroethylene vapours do not produce dominant lethal mutations in male mice. Arch Toxicol (1980) 0.75
[Recommendations of the Scientific Council 1968. 8. Teaching capacity]. Zahnarztl Mitt (1968) 0.75
[Recommendations of the scientific council 1968. XII. A wave of new highschool graduates is coming up]. Zahnarztl Mitt (1968) 0.75
[Recommendations of the Scientific Council 1968. 13. Model 100]. Zahnarztl Mitt (1968) 0.75
[Study of the pharmacokinetics of morphocycline, tetraverine and oxytetracycline]. Farmakol Toksikol (1978) 0.75
The estimation of drug plasma levels in epileptics. Int J Clin Pharmacol Biopharm (1978) 0.75
[Various practical comments on microorbital complications]. Cesk Stomatol (1979) 0.75
[Basic requirements for controlled clinical studies of periodontal diseases]. Int Dent J (1978) 0.75
[A documentation for the question of the new generation in dentistry]. Zahnarztl Mitt (1968) 0.75
Problems in the kinetic evaluation of capacity-limited processes by means of the analog computer MEDA 82 T. Int J Clin Pharmacol Biopharm (1978) 0.75
[Enlargement of the sella in primary hypothyroidism]. Z Gesamte Inn Med (1981) 0.75
[Prognosis, chronification and therapeutic relations in unsatisfactorily improved secondary faulty developments with cardiovascular affections]. Psychiatr Neurol Med Psychol (Leipz) (1979) 0.75
[Interpretations and examples of Bugo-Z]. Zahnarztl Mitt (1965) 0.75
[Recommendations of the Scientific Council 1968. XI. It's a long way]. Zahnarztl Mitt (1968) 0.75
[Introduction of a model in industrial medicine--data utilization in occupational medicine]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie (1980) 0.75
[Recommendations for dental radiography methods]. Int Dent J (1978) 0.75
[Recommendations of the Scientific Council 1968. X. Fewer medical students--more dental students]. Zahnarztl Mitt (1968) 0.75
[Recommendations of the Scientific council. XIV. The "front" has spoken]. Zahnarztl Mitt (1969) 0.75
[Recommendations of the Scientific Council 1968. With optimism toward the future]. Zahnarztl Mitt (1969) 0.75
[Recommendations for the handling of mercury]. Int Dent J (1978) 0.75
[Unilateral exophthalmos and arteriovenous aneurysm in the region of the Sylvian vessel group in an infant]. Klin Monbl Augenheilkd (1967) 0.75
[Recommendation of the Scientific Council 1968. V. All provinces must cooperate]. Zahnarztl Mitt (1968) 0.75
[Electronic data processing as an aid in occupational medicine documentation - methods, experiences, perspectives]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie (1982) 0.75